Dana-Farber Cancer Institute: Trial of CBD for Cancer-Related Anxiety Demonstrates Intriguing Findings
December 18, 2024
December 18, 2024
BOSTON, Massachusetts, Dec. 18 (TNSres) -- The Dana-Farber Cancer Institute issued the following news release:
RESEARCH SUMMARY
Study Title: Cannabidiol for Scan-related Anxiety in Women with Advanced Breast Cancer: A Randomized Clinical Trial
Publication: JAMA Network Open
Dana-Farber Cancer Institute authors: Manan M. Nayak, PhD, Peter Chai, MD, Paul J. Catalano, ScD, William Pirl, MD, MPH, James A. Tulsky, MD, Stephanie Tung, MD, Nancy U. Li . . .
RESEARCH SUMMARY
Study Title: Cannabidiol for Scan-related Anxiety in Women with Advanced Breast Cancer: A Randomized Clinical Trial
Publication: JAMA Network Open
Dana-Farber Cancer Institute authors: Manan M. Nayak, PhD, Peter Chai, MD, Paul J. Catalano, ScD, William Pirl, MD, MPH, James A. Tulsky, MD, Stephanie Tung, MD, Nancy U. Li . . .